Search filters

List of works by Vandana G Abramson

A Randomized Placebo-Controlled Phase 2 Trial Evaluating Exemestane With or Without Enzalutamide in Patients With Hormone Receptor-positive Breast Cancer

scientific article published on 28 September 2020

A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancer

scientific article published on 31 July 2019

Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer

scientific article published on 21 August 2020

Circulating Neuregulin During the Transition From Stage A to Stage B/C Heart Failure in a Breast Cancer Cohort ⬇️

scientific article published on January 1, 2013

Improving survival and limiting toxicity: latest advances in treating human epidermal growth factor receptor 2 overexpressing breast cancer ⬇️

scientific article published on May 1, 2012

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

scientific article published on 25 June 2018

New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available ⬇️

scientific article published on January 19, 2011

Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer ⬇️

scientific article published on November 16, 2011

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

scientific article

TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer

scientific article published on 10 December 2019

Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report ⬇️

scientific article published on April 7, 2013

Paulina is supported by:

About Paulina

Help